199 related articles for article (PubMed ID: 36430423)
21. Ceramide conversion to sphingosine-1-phosphate is essential for survival in C3H10T1/2 cells.
Castillo SS; Teegarden D
J Nutr; 2001 Nov; 131(11):2826-30. PubMed ID: 11694603
[TBL] [Abstract][Full Text] [Related]
22. [Sphingolipid-mediated apoptotic signaling pathways].
Cuvillier O; Andrieu-Abadie N; Ségui B; Malagarie-Cazenave S; Tardy C; Bonhoure E; Levade T
J Soc Biol; 2003; 197(3):217-21. PubMed ID: 14708343
[TBL] [Abstract][Full Text] [Related]
23. Activation of sphingosine kinase-1 in cancer: implications for therapeutic targeting.
Cuvillier O; Ader I; Bouquerel P; Brizuela L; Malavaud B; Mazerolles C; Rischmann P
Curr Mol Pharmacol; 2010 Jun; 3(2):53-65. PubMed ID: 20302564
[TBL] [Abstract][Full Text] [Related]
24. A signaling cascade mediated by ceramide, src and PDGFRβ coordinates the activation of the redox-sensitive neutral sphingomyelinase-2 and sphingosine kinase-1.
Cinq-Frais C; Coatrieux C; Grazide MH; Hannun YA; Nègre-Salvayre A; Salvayre R; Augé N
Biochim Biophys Acta; 2013 Aug; 1831(8):1344-56. PubMed ID: 23651497
[TBL] [Abstract][Full Text] [Related]
25. FTY720 induces apoptosis of M2 subtype acute myeloid leukemia cells by targeting sphingolipid metabolism and increasing endogenous ceramide levels.
Chen L; Luo LF; Lu J; Li L; Liu YF; Wang J; Liu H; Song H; Jiang H; Chen SJ; Luo C; Li KK
PLoS One; 2014; 9(7):e103033. PubMed ID: 25050888
[TBL] [Abstract][Full Text] [Related]
26. Multifaceted roles of sphingosine-1-phosphate: how does this bioactive sphingolipid fit with acute neurological injury?
Singh IN; Hall ED
J Neurosci Res; 2008 May; 86(7):1419-33. PubMed ID: 18058948
[TBL] [Abstract][Full Text] [Related]
27. Ceramide metabolism is affected by obesity and diabetes in human adipose tissue.
Błachnio-Zabielska AU; Pułka M; Baranowski M; Nikołajuk A; Zabielski P; Górska M; Górski J
J Cell Physiol; 2012 Feb; 227(2):550-7. PubMed ID: 21437908
[TBL] [Abstract][Full Text] [Related]
28. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia.
Melland-Smith M; Ermini L; Chauvin S; Craig-Barnes H; Tagliaferro A; Todros T; Post M; Caniggia I
Autophagy; 2015 Apr; 11(4):653-69. PubMed ID: 25853898
[TBL] [Abstract][Full Text] [Related]
29. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
[TBL] [Abstract][Full Text] [Related]
30. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
Gatt S; Dagan A
Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
[TBL] [Abstract][Full Text] [Related]
31. The effect of enterolactone on sphingolipid pathway and hepatic insulin resistance development in HepG2 cells.
Charytoniuk T; Iłowska N; Berk K; Drygalski K; Chabowski A; Konstantynowicz-Nowicka K
Life Sci; 2019 Jan; 217():1-7. PubMed ID: 30468835
[TBL] [Abstract][Full Text] [Related]
32. Sphingolipids in psychiatric disorders and pain syndromes.
Mühle C; Reichel M; Gulbins E; Kornhuber J
Handb Exp Pharmacol; 2013; (216):431-56. PubMed ID: 23563670
[TBL] [Abstract][Full Text] [Related]
33. Sphingosine-1-phosphate is a mediator of TNF-α action on the Na+/K+ ATPase in HepG2 cells.
Dakroub Z; Kreydiyyeh SI
J Cell Biochem; 2012 Jun; 113(6):2077-85. PubMed ID: 22271589
[TBL] [Abstract][Full Text] [Related]
34. Cancer treatment strategies targeting sphingolipid metabolism.
Oskouian B; Saba JD
Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655
[TBL] [Abstract][Full Text] [Related]
35. Multiple sphingolipid abnormalities following cerebral microendothelial hypoxia.
Testai FD; Kilkus JP; Berdyshev E; Gorshkova I; Natarajan V; Dawson G
J Neurochem; 2014 Nov; 131(4):530-40. PubMed ID: 25060904
[TBL] [Abstract][Full Text] [Related]
36. Bimodal regulation of ceramidase by interleukin-1beta. Implications for the regulation of cytochrome p450 2C11.
Nikolova-Karakashian M; Morgan ET; Alexander C; Liotta DC; Merrill AH
J Biol Chem; 1997 Jul; 272(30):18718-24. PubMed ID: 9228043
[TBL] [Abstract][Full Text] [Related]
37. Functions of neutral ceramidase in the Golgi apparatus.
Sakamoto W; Coant N; Canals D; Obeid LM; Hannun YA
J Lipid Res; 2018 Nov; 59(11):2116-2125. PubMed ID: 30154232
[TBL] [Abstract][Full Text] [Related]
38. Nerve growth factor, sphingomyelins, and sensitization in sensory neurons.
Nicol GD
Sheng Li Xue Bao; 2008 Oct; 60(5):603-4. PubMed ID: 18958367
[TBL] [Abstract][Full Text] [Related]
39. Deregulation of sphingolipid metabolism in Alzheimer's disease.
He X; Huang Y; Li B; Gong CX; Schuchman EH
Neurobiol Aging; 2010 Mar; 31(3):398-408. PubMed ID: 18547682
[TBL] [Abstract][Full Text] [Related]
40. Involvement of neutral ceramidase in ceramide metabolism at the plasma membrane and in extracellular milieu.
Tani M; Igarashi Y; Ito M
J Biol Chem; 2005 Nov; 280(44):36592-600. PubMed ID: 16126722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
